Internal Medicine, Rheumatology · Wichita Falls, TX
NPI
1326228339
Since 2007
Specialty
Internal Medicine, Rheumatology
Code 207RR0500X
Group practices
1
Medicare group memberships
Hospitals
2
Hospital affiliations
4007 Call Field Rd Ste E
Wichita Falls, TX, 76308
Phone (940) 264-2624
Groups this clinician bills Medicare through
Medicare paid, 2024
$3.6M
429,571 services
Medicare patients, 2024
653
Average age 72
Drug cost, 2024
$7.1M
7,797 prescriptions
Company payments, 2025
$6,026
From 23 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Erin K Loe was code J0717 (injection, certolizumab pegol, 1 mg (code may be used for medicare when drug administered under the direct supervision of a physician, not for use when drug is self administered)), 118,000 times for 37 patients. In total Erin K Loe billed 429,571 services in 47 codes, and Medicare paid $3.6M.
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2025-01-17.
| Code | Setting | Services | Patients | Paid per service | Medicare paid |
|---|
| J0717 Injection, certolizumab pegol, 1 mg (code may be used for medicare when drug administered under the direct supervision of a physician, not for use when drug is self administered) | Office | 118,000 | 37 | $3.60 | $425K |
| J3262 Injection, tocilizumab, 1 mg | Office | 117,177 | 40 | $4.57 | $536K |
| J1602 Injection, golimumab, 1 mg, for intravenous use | Office | 92,251 | 122 | $8.99 | $830K |
| J3111 Injection, romosozumab-aqqg, 1 mg | Office | 52,080 | 41 | $8.59 | $448K |
| J0129 Injection, abatacept, 10 mg (code may be used for medicare when drug administered under the direct supervision of a physician, not for use when drug is self administered) | Office | 16,850 | 31 | $33.90 | $571K |
| J0897 Injection, denosumab, 1 mg | Office | 7,560 | 81 | $20.64 | $156K |
| J1745 Injection, infliximab, excludes biosimilar, 10 mg | Office | 4,412 | 21 | $24.83 | $110K |
| J3301 Injection, triamcinolone acetonide, not otherwise specified, 10 mg | Office | 1,862 | 241 | $0.73 | $1,361 |
| 96372 Injection Administration | Office | 1,669 | 296 | $10.22 | $17K |
| 99214 Office E&M - Established | Office | 1,560 | 568 | $88.32 | $138K |
| J1885 Injection, ketorolac tromethamine, per 15 mg | Office | 954 | 190 | $0.50 | $478 |
| J2919 Injection, methylprednisolone sodium succinate, 5 mg | Office | 840 | 55 | $0.22 | $186 |
| 96365 Intravenous Infusion, Hydration | Office | 699 | 145 | $43.05 | $30K |
| 96413 Chemotherapy Administration | Office | 399 | 76 | $89.62 | $36K |
| 96375 Injection Administration | Office | 215 | 67 | $11.20 | $2,408 |
By year: 2022 $1.9M for 175,203 services; 2023 $3.0M for 301,314 services; 2024 $3.6M for 429,571 services.
Medicare prescription drug claims, 2024
In 2024, the drug Erin K Loe prescribed most often to Medicare patients was Hydroxychloroquine Sulfate, with 1,687 prescriptions and refills. In total Erin K Loe wrote 7,797 Medicare prescriptions that cost $7.1M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Hydroxychloroquine Sulfate Generic | 1,687 | 2,764 | 380 | $50K |
| Methotrexate Methotrexate Sodium | 1,096 | 1,567 | 224 | $18K |
| Leflunomide Generic | 661 | 939 | 144 | $24K |
| Prednisone Generic | 500 | 675 | 250 | $1,918 |
| Sulfasalazine Generic | 467 | 650 | 113 | $8,156 |
| Duloxetine Hcl Generic | 392 | 647 | 105 | $6,062 |
| Gabapentin Generic | 368 | 507 | 92 | $3,271 |
| Tizanidine Hcl Generic | 255 | 374 | 69 | $2,283 |
| Folic Acid Generic | 220 | 400 | 57 | $1,254 |
| Enbrel Sureclick Etanercept | 190 | 194 | 40 | $1.4M |
| Humira(Cf) Pen Adalimumab | 188 | 189 | 27 | $1.9M |
| Orencia Clickject Abatacept | 177 | 181 | 29 | $1.0M |
| Alendronate Sodium Generic | 155 | 311 | 44 | $1,179 |
| Tramadol Hcl Generic | 147 | 153 | 36 | $1,390 |
| Rinvoq Upadacitinib | 139 | 155 | 23 | $980K |
Brand drugs: 1,433 claims; generic drugs: 6,353 claims; opioid claims: 210.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Erin K Loe $6,026 ($6,026 in general payments such as food, travel and fees) from 23 companies. The largest payer was Janssen Biotech, Inc. with $2,752.
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. JNJ | 12 | $2,752 |
| Amgen Inc. AMGN | 31 | $674 |
| Abbvie Inc. ABBV | 26 | $500 |
| UCB, Inc. UCB.BR | 16 | $376 |
| GlaxoSmithKline, LLC. GSK | 16 | $305 |
| ANI Pharmaceuticals, Inc. ANIP | 15 | $270 |
| AstraZeneca Pharmaceuticals LP AZN | 8 | $189 |
| Organon LLC OGN | 5 | $153 |
| Genzyme Corporation SNY | 4 | $135 |
| E.R. Squibb & Sons, L.L.C. BMY | 6 | $117 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.